Almost every new ground-breaking cancer treatment has been a result of clinical trials research. ANZUP works towards improving treatments and outcomes by undertaking clinical trials in below the belt (prostate, bladder, kidney, penile and testicular) cancer. These trials and research allows us to test better ways of helping people.
Some of our community have generously shared their experiences with cancer, clinical trials and fundraising. Here you can read about what we do, why we do it, why these cancers need to be talked about and why clinical trials are so important.
And if you have a story you would like to share, contact us at email@example.com
Precision medicine is the concept of targeting the right patient for the right treatment at the right time. ENZA-p is a clinical trial that aims to use new theranostic agents to allow more accurate prognostic decision making.
Globally, penile cancer is an uncommon cancer with a reported incidence of 1 per 100,000 men diagnosed. There is a range of treatments for penile cancer depending on the stage of disease.
Mike is 57, lives in Melton Victoria and married with 3 adult children and 4 grandchildren. His life was about family, running, work and the motor sport club and was pretty healthy until his diagnosis with bladder cancer in December 2016.
In Australia someone is diagnosed with cancer every four minutes. Every one of those patients would benefit from exercise but only one in ten will exercise enough during and after their cancer treatment.
Dr Gavin Marx and his patient Rob Palmer talk about their shared decision making of the treatment choices for Rob’s prostate cancer.
In July 2016, aged 38, Catherine McFarlane went from juggling the roles of wife, mother, daughter, sister and dietitian to someone who could add cancer to the list of their daily juggles and struggles.
Rural communities have had access to telehealth for a while - but when COVID-19 led to increased social distancing and isolation measures, there was a need to expand the offering.